Q
Qihua He
Researcher at Guangzhou Medical University
Publications - 24
Citations - 531
Qihua He is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Lung cancer & non-small cell lung cancer (NSCLC). The author has an hindex of 9, co-authored 24 publications receiving 358 citations.
Papers
More filters
Journal ArticleDOI
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
Wenhua Liang,Jiaxi He,Yaxing Shen,Jianfei Shen,Qihua He,Jianrong Zhang,Gening Jiang,Qun Wang,Lunxu Liu,Shugeng Gao,Deruo Liu,Zheng Wang,Zhihua Zhu,Calvin S.H. Ng,Chia-Chuan Liu,René Horsleben Petersen,Gaetano Rocco,Thomas A. D'Amico,Alessandro Brunelli,Haiquan Chen,Xiuyi Zhi,Bo Liu,Yixin Yang,Wensen Chen,Qian Zhou,Jianxing He +25 more
TL;DR: A greater number of ELNs is associated with more-accurate node staging and better long-term survival of resected NSCLC and is recommended as the cut point for evaluating the quality of LN examination or prognostic stratification postoperatively for patients with declared node-negative disease.
Journal ArticleDOI
Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report
Wenhua Liang,Qihua He,Ying Chen,Shaokun Chuai,Weiqiang Yin,Wei Wang,Guilin Peng,Caicun Zhou,Caicun Zhou,Jianxing He +9 more
TL;DR: This is the first report of the existence of ALK rearrangement in metastatic lesions in an EGFR mutated patient and highlighted the feasibility and advantages of using ctDNA multiplex genotyping in identifying the heterogeneity across lesions and the resistance mechanism of targeted treatments.
Journal ArticleDOI
EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.
Kai Dong,Wenhua Liang,Shen Zhao,Minzhang Guo,Qihua He,Caichen Li,Haiqing Song,Jianxing He,Xiaojun Xia +8 more
TL;DR: EGFR-TKIs plus brain RT is superior to EGFR- TKIs alone in the management of EGfr-mutated NSCLC patients with BM, of which the benefits might be influenced by age, BM-related symptoms and mutation type.
Journal ArticleDOI
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.
Qihua He,Peiling Xin,Mingzhe Zhang,Si Jiang,Jianrong Zhang,Shengyi Zhong,Yang Liu,Minzhang Guo,Xuewei Chen,Xiaojun Xia,Zhenkui Pan,Chenye Guo,Xiuyu Cai,Wenhua Liang,Jianxing He +14 more
TL;DR: There was no significant difference in postoperative DFS between EGFR-mutant patients and wild-type with resected NSCLC and there is still insufficient evidence to support different postoperative treatment strategies (especially for stage I) for both mutated andWild-type patients.
Journal ArticleDOI
The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures.
Ziying Lin,Yutong Xu,Yutong Xu,Yaxiong Zhang,Qihua He,Jianrong Zhang,Jianxing He,Wenhua Liang +7 more
TL;DR: This meta-analysis indicated that patients with larger tumors, regional lymph node metastases, or poor-differentiated tumors were associated with a higher PD-L1 expression rate; in addition the expression rate of PD- L1 in Asians might be higher than that of Caucasians.